BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 35592395)

  • 1. Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.
    Grover SP; Mackman N
    Front Cardiovasc Med; 2022; 9():878199. PubMed ID: 35592395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serpins in thrombosis, hemostasis and fibrinolysis.
    Rau JC; Beaulieu LM; Huntington JA; Church FC
    J Thromb Haemost; 2007 Jul; 5 Suppl 1(Suppl 1):102-15. PubMed ID: 17635716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions.
    Chan ED; King PT; Bai X; Schoffstall AM; Sandhaus RA; Buckle AM
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
    Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
    Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpins, New Therapeutic Targets for Hemophilia.
    Aymonnier K; Kawecki C; Arocas V; Boulaftali Y; Bouton MC
    Thromb Haemost; 2021 Mar; 121(3):261-269. PubMed ID: 32987444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
    Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.
    Pike RN; Buckle AM; le Bonniec BF; Church FC
    FEBS J; 2005 Oct; 272(19):4842-51. PubMed ID: 16176258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis.
    Corral J; González-Conejero R; Hernández-Espinosa D; Vicente V
    Br J Haematol; 2007 Apr; 137(2):99-108. PubMed ID: 17391489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SERPINs-From Trap to Treatment.
    Sanrattana W; Maas C; de Maat S
    Front Med (Lausanne); 2019; 6():25. PubMed ID: 30809526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic SERPINs: Improving on Nature.
    Maas C; de Maat S
    Front Cardiovasc Med; 2021; 8():648349. PubMed ID: 33869308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure function analysis of serpin super-family: "a computational approach".
    Singh P; Jairajpuri MA
    Protein Pept Lett; 2014; 21(8):714-21. PubMed ID: 23855665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
    Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic Disorders.
    Bianchini EP; Auditeau C; Razanakolona M; Vasse M; Borgel D
    Front Cardiovasc Med; 2020; 7():622778. PubMed ID: 33490121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate/heparin glycosaminoglycan binding alters inhibitory profile and enhances anticoagulant function of conserved Amblyomma americanum tick saliva serpin 19.
    Radulović ŽM; Mulenga A
    Insect Biochem Mol Biol; 2017 Jan; 80():1-10. PubMed ID: 27845251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpins, the vasculature, and viral therapeutics.
    Richardson J; Viswanathan K; Lucas A
    Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
    Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
    Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors with conformational effects on haemostatic serpins: implications in thrombosis.
    Hernández-Espinosa D; Ordóñez A; Vicente V; Corral J
    Thromb Haemost; 2007 Sep; 98(3):557-63. PubMed ID: 17849043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.